SAINT BELLA GROUP LIMITED
HHKEX:25082.59
HKD
+0.05
(+1.97%)
ISIN
KYG7774B1077
CUSIP
G7774B107
Return %
Stock
S&P 500
1Y
-59.08
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Xiang Hua
- Full Time Employees
- 1,755
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Building 6, Information Port Phase 6 Hangzhou ZH China
- IPO Date
- Jun 26, 2025
- Website
- saintbella.com
- Similar Companies
- Business
- Saint Bella Inc. (2508.HK), a Cayman Islands-incorporated holding company, operates as a leading provider of premium postpartum care, family health, and recovery services primarily in China, Hong Kong, Singapore, and the United States. The company offers postpartum care and confinement services under the Saint Bella, Bella Isla, and Baby Bella brands, featuring luxury centers with 24-hour personalized nursing, art therapy for emotional well-being, and full-cycle women's care; home-based care services under the PrimeCare for Family brand, pairing families with specialized baby and elder care professionals; women's functional food and nutritional supplements under the GuangHeTang brand, acquired in 2022 and reformulated for postpartum and maternal health needs; and supportive products including lingerie under the S-bra brand. Founded in 2017 and headquartered in Hangzhou, Zhejiang Province, China, Saint Bella serves high-net-worth individuals and lifestyle-conscious families across its multi-brand portfolio in the healthcare facilities sector, with approximately 1,600 employees and operations focused on asset-light models in high-end hotels and villas. In June 2025, the company completed its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange, raising capital amid prior funding from investors including Tencent, China Life Investment, Sun Hung Kai, and Swire Properties; in July-August 2025, Goldstream Investment acquired a 0.3% stake through open-market purchases valued at HK$13.82 million; it issued a first-half 2025 profit alert forecasting 25% revenue growth to 448 million yuan and a swing to adjusted net profit of 38 million yuan; and expanded internationally with postpartum centers in Singapore since October 2023 and Los Angeles.